[DOI] [PubMed] [Google Scholar] 136.Fang S., et al
GLP-1 medications offer significant health benefits but come with potential side effects
However, recent research has revealed a potentially groundbreaking application: using GLP-1 receptor agonists to curb addiction to substances such as alcohol, nicotine, and opioids
Safety summary with warnings Warnings - Zepbound may cause tumors in the thyroid, including thyroid cancer
The MHRA has approved these agents for specific indications, and NICE provides guidance on their use within the NHS, typically recommending them when other treatments have proven insufficient or when specific clinical criteria are met
An early FAERS analysis suggested an elevated risk, prompting the FDA to investigate